Trump started the Section 232 probe into pharma in the spring of 2025, using it as a lever for trade negotiations and MFN ...

For Lebrat, it goes back to simplicity of use: the synthetic persona leverages the data a team already has. Synthetic ...

Sebnem Avsar Tuna, general manager of Novo Nordisk UK, reflected on how advances in biology and research have helped reshape ...

For Korsana, merging with Cyclerion gives it a fast track to a Nasdaq listing without the complexities of going down the IPO ...

The 2026 agenda is anchored by a distinguished roster of speakers who are actively redefining the boundaries of science, ...

In a subgroup of black women enrolled in a US breast cancer registry called BEST, women deemed to have low-risk tumours using the MammaPrint test had a 97.7% recurrence-free rate after 10 years, the ...

The FDA has approved orforglipron, under the Foundayo trade name, in just 50 days, thanks to a fast track review under the ...

"Through the integration of virtual control groups, EMA also seeks to improve the relevance and predictability of ...

At the LSX World Congress in Lisbon this year, web editor Nicole Raleigh stepped aside from the hustle and bustle to speak ...

Three behavioural phenomena are particularly consequential in screening and prevention research: ...

Large-scale flow cytometry delivers critical biological insight by enabling multidimensional analysis of individual cells, ...

Mitapivat has been approved in the US under the Pyrukynd trade name since 2022 as a treatment for haemolytic anaemia in ...